Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
After delays, brush with truck does little to up Mitsubishi’s MRJ in regional jet dogfight with industry giants

22h japantimes.co.jp
FARNBOROUGH, ENGLAND/SINGAPORE – Japan’s Mitsubishi Aircraft Corp., trying to keep its new regional jet on track after series of delays, was forced to cancel a demo flight for the world’s aerospace industry on Tuesday after the jet was hit by a truck.
MHVYF BOE SKYW ALNPY JBLU ALNPF 9202 BA 7011

0
After delays, Japan's regional jet faces dogfight with industry giants

2018-07-17 reuters
FARNBOROUGH, England/SINGAPORE, July 17 (Reuters) - Japan’s Mitsubishi Aircraft Corp, trying to keep its new regional jet on track after series of delays, was forced to cancel a demo flight for the world’s aerospace industry on Tuesday after the jet was hit by a truck.
MHVYF BOE SKYW ALNPY JBLU ALNPF 9202 BA 7011

0
After delays, Japan's regional jet faces dogfight with industry giants

2018-07-17 reuters
FARNBOROUGH, England/SINGAPORE (Reuters) - Japan’s Mitsubishi Aircraft Corp, trying to keep its new regional jet on track after series of delays, was forced to cancel a demo flight for the world’s aerospace industry on Tuesday after the jet was hit by a truck.
MHVYF BOE SKYW ALNPY BDRPF JBLU ALNPF 9202 BA 7011

0
Japan's regional jet not flying so high after air show prang

2018-07-17 reuters
FARNBOROUGH, England (Reuters) - Japan’s efforts to show off its new regional jet, the MRJ, were dealt another setback on Tuesday after a prang forced it to skip a flying display at the Farnborough Airshow.
ALNPY ALNPF 9202

0
Japan's ANA cancels more flights for engine inspection

2018-07-12 channelnewsasia
Japanese airline ANA Holdings canceled 330 domestic flights from July 23 through July 31, and warned of further cancellations in August as it continues to inspect engines built by Rolls-Royce .
ALNPY ALNPF 9202

0
Japan's ANA cancels more flights for engine inspection

2018-07-12 reuters
TOKYO (Reuters) - Japanese airline ANA Holdings (9202.T) canceled 330 domestic flights from July 23 through July 31, and warned of further cancellations in August as it continues to inspect engines built by Rolls-Royce (RR.L).
ALNPY ALNPF 9202

0
ANA cancels another 176 domestic flights for engine inspections, with more to come

2018-07-10 japantimes.co.jp
ANA Holdings Inc. will cancel another 176 domestic flights between Friday and July 22 to inspect Rolls-Royce engines on Boeing 787 aircraft after already calling off 113 flights for the same reason.
ALNPY ALNPF 9202

0
UPDATE 1-Japan's ANA cancels 176 more flights for Rolls-Royce engine checks

2018-07-09 reuters
TOKYO, July 9 (Reuters) - Japanese airline ANA Holdings on Monday canceled 176 flights from July 13 through July 22 to inspect Trent 1000 engines built by Rolls-Royce , adding to 113 flights it had canceled for the preceding week.
BOE ALNPY ALNPF 9202 BA

0
Japan's ANA cancels 176 more flights for engine inspection

2018-07-09 reuters
TOKYO (Reuters) - Japanese carrier ANA Holdings on Monday canceled 176 flights from July 13 through July 22 to inspect its Rolls-Royce Holdings engines, in addition to 113 flights it already canceled for the preceding week.
BOE ALNPY ALNPF 9202 BA

0
ANA Holdings, Sojitz Form ANA Business Jet In Joint Venture

2018-07-07 aviationweek
ANA Holdings and Sojitz announced a joint venture, ANA Business Jet. Operations began July 2 out of Los Angeles and Chicago. ANA Holdings has signed a memorandum of understanding with Honda Aircraft to utilize HondaJets for charter flights.
ALNPY ALNPF 9202

0
ANA to scrap 113 flights for Rolls-Royce engine inspections

2018-07-05 japantimes.co.jp
ANA Holdings Inc., Japan’s largest airline, will cancel 113 domestic flights for mandatory checks to help assess possible glitches in the Rolls-Royce Holdings PLC engines powering its Boeing Co. 787 Dreamliners.
BOE ALNPY ALNPF 9202 BA

0
Japan's ANA to cancel 113 domestic flights to inspect Rolls-Royce engines

2018-07-04 theedgemarkets
TOKYO (July 4): Japanese airline ANA Holdings Inc said it will cancel 113 domestic flights between July 6 through July 12 to inspect Rolls-Royce Holdings Plc engines for compressor issues that have led to service interruptions for airlines globally.
ANZLY BOE AIR ALNPY ANZFF ALNPF ANZFY 9202 BA AIZ

0
Japan’s ANA to cancel 113 domestic flights to inspect Rolls-Royce engines

2018-07-04 malaymail
TOKYO, July 4 — Japanese airline ANA Holdings Inc said it will cancel 113 domestic flights between July 6 through July 12 to inspect Rolls-Royce Holdings Plc engines for compressor issues that have led to service interruptions for airlines globally.
ANZLY BOE AIR ALNPY ANZFF ALNPF ANZFY 9202 BA AIZ

0
Japan's ANA to cancel 113 domestic flights to inspect Rolls-Royce engines - Channel NewsAsia

2018-07-04 channelnewsasia
Japanese airline ANA Holdings Inc said it will cancel 113 domestic flights between July 6 through July 12 to inspect Rolls-Royce Holdings Plc engines for compressor issues that have led to service interruptions for airlines globally.
ANZLY BOE AIR ALNPY ANZFF ALNPF ANZFY 9202 BA AIZ

0
Japan's ANA to cancel 113 domestic flights to inspect Rolls-Royce engines

2018-07-04 reuters
TOKYO (Reuters) - Japanese airline ANA Holdings Inc (9202.T) said it will cancel 113 domestic flights between July 6 through July 12 to inspect Rolls-Royce Holdings Plc (RR.L) engines for compressor issues that have led to service interruptions for airlines globally.
ANZLY BOE AIR ALNPY ANZFF ALNPF ANZFY 9202 BA AIZ

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 601490006